7 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... #Neuro #Erenumab ... #Migraine #CGRP ... #VisualAbstract ... #NEJM
How to use C-reactive protein (CRP)- Review https://ep.bmj.com/content/early/2018/07/19/archdischild-2018-315079

 - An CRP alone cannot be used to
C-reactive protein (CRP ... 315079 - An CRP ... CReactiveProtein #VisualAbstract ... #Review #Peds # ... Pediatrics #Diagnosis
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
NEJMoa1101549 #EBM ... #Peds #Pediatrics ... Boluses #Africa #NEJM ... #VisualAbstract
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
Infusion Rates for Pediatric ... NEJM 2018 https ... TessaRDavis #EBM ... #VisualAbstract ... #Peds #Pediatrics